A landmark preclinical study has unveiled a novel gene therapy designed to neutralize chronic pain at its source within the…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…
Read More
Ludwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous Leukemia
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
The Court Said Talk Therapy Is Protected Speech, Not Medical Conduct
In a landmark decision that reverberated through legal and advocacy circles, the U.S. Supreme Court ruled in late March that…
Read More
Deciphering the Distinct Roles of BET Proteins: A New Paradigm for Targeted Cancer Therapy Emerges from Max Planck Research
The global fight against cancer, a disease projected to claim over 10 million lives annually, continues to drive intense research…
Read More
Apnimed Secures Up to $150 Million in Credit Facility to Fuel Potential US Launch of Obstructive Sleep Apnea Therapy AD109
Boston, MA – – Apnimed, a clinical-stage biopharmaceutical company focused on developing novel therapies for sleep-related breathing disorders, has announced…
Read More
Penn Researchers Develop Breakthrough Non-Addictive Gene Therapy Targeting Brain Pain Circuits to Combat Chronic Pain and Opioid Crisis
A new preclinical study has identified a gene therapy that directly targets pain-processing areas in the brain while avoiding the…
Read More
European Commission Approves Keytruda Combination Therapy for PD-L1-Positive Platinum-Resistant Ovarian Cancer
The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…
Read More
Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
The landscape of hematological oncology is facing a potential paradigm shift following a comprehensive study led by Ludwig Cancer Research,…
Read More
The Court said talk therapy is protected speech, not medical conduct
The United States Supreme Court, in a landmark decision delivered at the end of March, has ruled that Colorado’s statute…
Read More
